ArticleMolecular oncology2020

The potential of combined mutation sequencing of plasma circulating cell-free DNA and matched white blood cells for treatment response prediction.

Paul van der Leest et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.